ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 162 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2021. The put-call ratio across all filers is 0.87 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,017,530 | +37.9% | 78,964 | +54.8% | 0.00% | – |
Q2 2023 | $1,463,254 | +23.8% | 51,020 | +3.5% | 0.00% | – |
Q1 2023 | $1,182,152 | -18.3% | 49,318 | -42.2% | 0.00% | -100.0% |
Q4 2022 | $1,447,401 | +214.0% | 85,342 | +174.8% | 0.00% | – |
Q3 2022 | $461,000 | -20.7% | 31,052 | -15.9% | 0.00% | – |
Q2 2022 | $581,000 | -86.2% | 36,928 | -76.4% | 0.00% | -100.0% |
Q1 2022 | $4,225,000 | -46.7% | 156,709 | -26.8% | 0.00% | -66.7% |
Q4 2021 | $7,926,000 | -28.1% | 214,153 | -7.2% | 0.00% | -25.0% |
Q3 2021 | $11,028,000 | +242.5% | 230,798 | +142.6% | 0.00% | +300.0% |
Q2 2021 | $3,220,000 | -56.2% | 95,150 | -46.6% | 0.00% | -66.7% |
Q1 2021 | $7,356,000 | -57.6% | 178,100 | -55.5% | 0.00% | -66.7% |
Q4 2020 | $17,366,000 | +49.1% | 400,326 | +47.5% | 0.01% | +28.6% |
Q3 2020 | $11,646,000 | +13.4% | 271,456 | +23.5% | 0.01% | 0.0% |
Q2 2020 | $10,273,000 | +4025.7% | 219,788 | +1099.3% | 0.01% | – |
Q1 2020 | $249,000 | – | 18,327 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |